Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Protecting Your Image in the Age of AI-Generated “Deepfakes”

Client Alert

The rapid evolution of artificial intelligence (AI) has transformed how we create and consume digital content. While AI offers innovative solutions in business, entertainment, and communication, it also poses significant risks. Among the most troubling developments in AI is the proliferation of AI-generated fraudulent content, often called “deepfakes”.

A “deepfake” can be created by malicious actors who manipulate existing, legitimate images, videos, and audio recordings to create new fraudulent content. This fraudulent content is then used to deceive, defraud, and/or impersonate legitimate content from real individuals and brands. For example, our firm recently represented a business professional whose original video content was scraped from the internet, edited using AI, and re-uploaded to a platform where they did not have an account. The altered videos were then used to promote a fraudulent product falsely attributed to our client, leading to reputational harm and consumer confusion.

Currently, the capabilities of AI can be used to create fraudulent content such as:

1. “Deepfake” Videos that Misrepresent Endorsements or Beliefs

AI-generated “deepfake” videos can convincingly manipulate existing, legitimate video footage to make it appear as though a person in the existing footage is saying or doing something they never did in the original video. These fakes are now being used in:

  • fake endorsements where a person appears to promote a product or service they’re not associated with
  • manipulated interviews or speeches that falsely portray an individual as holding controversial or offensive opinions
  • fraudulent ads where an individual is inserted into a fraudulent video to lend credibility to a product/scam

The result is not only reputational harm to the original party but also the potential for legal liability if consumers act on these “deepfakes”.

2. AI “Voice Clones” Used in Fraud And Impersonation

AI voice synthesis tools can now clone a person’s speech patterns, tone, and inflection with remarkable and convincing accuracy. These voice clones are now being used to:

  • place scam calls in which the voice of a trusted colleague, family member, or executive is replicated
  • create fake voicemails or recordings such as fake customer service lines, political robocalls, or misleading audio snippets shared on social media
  • bypass security checks, especially those using voice authentication systems

Because voice is such a personal and persuasive medium, these scams can be particularly effective and often difficult to detect.

3. Repackaged or Stolen Content Misused on Digital Platforms

In many cases, bad actors scrape legitimate, existing content such as videos, podcasts, social media posts, or livestreams from the internet and re-upload them—often out of context—making it seem as though the speaker supports a particular viewpoint or product. The content can also be re-uploaded with an AI narration or branding, suggesting affiliation with companies or causes the original party does not endorse. This not only infringes intellectual property rights but also misleads audiences and can divert income from the rightful content creator.

How to detect AI “Deepfakes”

Despite rapid improvements in AI, many fraudulent AI video, audio, and other content may display subtle flaws such as:

  • Awkward or unnatural facial movements
  • lip-syncing issues (the words spoken do not match the way the person’s mouth is moving)
  • Flat, unnatural, or robotic speech patterns
  • Lighting or background inconsistencies
  • A lack of verification on official social media or websites from the person supposedly involved in the content

When in doubt, search for the original source and consult reputable news outlets and official pages.

What to do Next

If you discover that your image, voice, or content has been used without authorization, you may have both legal and practical remedies. First, report the content to the hosting platform. If your original content has been copied or altered, copyright law may provide grounds for removal. In addition, make sure to preserve the evidence—take screenshots, save links, and document any public confusion, customer complaints, or reputational fallout. Depending on your situation, you may have claims under defamation law, the right of publicity, consumer protection statutes, and/or tort law.

For more information, please contact Susan A. Jacobsen at 216.298.1452 x848 or sajacobsen@bmdllc.com.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.